Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04011813
Other study ID # 2014 HYPOTAURINE
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2014
Est. completion date May 1, 2019

Study information

Verified date June 2019
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Although it is widely used, slow freezing can induce strong functional and nuclear spermatic alterations reducing the chances of pregnancy. The study objective is to determinate the effects of the combination of hypotaurine supplementation and spermatozoa selection by Density Gradient Centrifugation (DGC) on human sperm functions and DNA quality during a freezing-thawing cycle.


Description:

This prospective study was performed on surplus semen after a density gradient centrifugation-frozen-thawing cycle. Samples were obtained from men undergoing routine semen analysis at the Center for Reproductive Medicine. Spermatozoa were selected by density gradient centrifugation, washed and frozen using a programmable device. Each step was performed in parallel with (H+ arm) or without (H- arm) 50mM hypotaurine supplementation. After thawing, investigator team compared for both conditions the total and progressive mobility, vitality, integrity of the acrosome, markers of Protein Kinase A (PKA) dependent capacitation intracellular signaling pathway and nuclear quality by measuring chromatin packaging, DNA fragmentation and oxidation and vacuoles presence in the spermatozoa head.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date May 1, 2019
Est. primary completion date August 1, 2018
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- None

Exclusion Criteria:

- None

Study Design


Intervention

Other:
Hypotaurine : antioxidant and osmoregulator
Hypotaurine has protective effects on sperm motility, capacitation and acrosome reaction and reduces apoptotic markers. Hypotaurine (50mM) was added in density gradient centrifugation, washing and cryopreservation media washing and cryopreservation media before spermatozoa freezing

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Université d'Auvergne, Centre National de la Recherche Scientifique, Université d'Auvergne, Institut National de la Santéet de la Recherche Médicale, University Hospital, Clermont-Ferrand, Hematology laboratory

Outcome

Type Measure Description Time frame Safety issue
Primary chromatin packaging labelled using aniline blue and chromomycin A3 Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of chromatin packaging labelled using aniline blue and chromomycin A3 Day 0
Primary DNA fragmentation using TUNEL assay Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of DNA fragmentation using TUNEL assay Day 0
Primary DNA oxidation assessed by 8-OHdG immunodetections Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of DNA oxidation assessed by 8-OHdG immunodetections Day 0
Primary vacuoles presence in the spermatozoa head using Motile Sperm Organelle Morphology Examination (MSOME) Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of vacuoles presence in the spermatozoa head using Motile Sperm Organelle Morphology Examination (MSOME) Day 0
Secondary vitality using Eosin Nigrosin Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of vitality using Eosin Nigrosin Day 0
Secondary motility total and progressive Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of motility total and progressive Day 0
Secondary integrity of the acrosome using Fluorescein IsoThioCyanate-Pisum Sativum Agglutinin (FITC-PSA) labelling Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of integrity of the acrosome using Fluorescein IsoThioCyanate-Pisum Sativum Agglutinin (FITC-PSA) labelling Day 0
Secondary markers of PKA-dependent capacitation intracellular signaling pathway assessing western blot Comparison after a cycle of freezing-thawing for both conditions, with or without hypotaurine supplementation of markers of PKA-dependent capacitation intracellular signaling pathway assessing western blot Day 0
See also
  Status Clinical Trial Phase
Completed NCT02032797 - Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone. Phase 4
Recruiting NCT03913208 - Priority to Cryopreservation Strategy (PCS) in IVF-ICSI Cycles N/A
Recruiting NCT06261658 - Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma N/A
Completed NCT04487639 - Presence of SARS-CoV-2 (COVID-19) in Semen: Impact on Fertility Preservation in Male Oncological Patients ? N/A
Withdrawn NCT02687880 - Testicular Tissue Cryopreservation for Fertility Preservation in Male Patients Facing Infertility-causing Diseases or Treatment Regimens
Completed NCT03153436 - The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation Phase 1/Phase 2
Completed NCT00521443 - Cryosurvival of Embryos From Dysmorphic Oocytes N/A